157 related articles for article (PubMed ID: 23615928)
1. Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization.
Sun J; Tu M; Han B; Xue X; Zhang Y; Wei J; Chen J; Lu Z; An Y; Cai B; Lv N; Jiang K; Miao Y; Gao W
Int J Oncol; 2013 Jul; 43(1):255-61. PubMed ID: 23615928
[TBL] [Abstract][Full Text] [Related]
2. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
[TBL] [Abstract][Full Text] [Related]
3. Nuclear vasohibin-2 promotes cell proliferation by inducing G0/G1 to S phase progression.
Ge Q; Zhou J; Tu M; Xue X; Li Z; Lu Z; Wei J; Song G; Chen J; Guo F; Jiang K; Miao Y; Gao W
Oncol Rep; 2015 Sep; 34(3):1327-36. PubMed ID: 26177649
[TBL] [Abstract][Full Text] [Related]
4. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
[TBL] [Abstract][Full Text] [Related]
5. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.
Koyanagi T; Suzuki Y; Komori K; Saga Y; Matsubara S; Fujiwara H; Sato Y
Cancer Sci; 2017 Mar; 108(3):512-519. PubMed ID: 28032401
[TBL] [Abstract][Full Text] [Related]
6. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of miR-200b/c by inhibiting vasohibin-2 in human retinal microvascular endothelial cells.
Ding Y; Hu Z; Luan J; Lv X; Yuan D; Xie P; Yuan S; Liu Q
Life Sci; 2017 Dec; 191():245-252. PubMed ID: 28882646
[TBL] [Abstract][Full Text] [Related]
8. Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.
Li Z; Tu M; Han B; Gu Y; Xue X; Sun J; Ge Q; Miao Y; Qian Z; Gao W
PLoS One; 2014; 9(3):e90358. PubMed ID: 24595063
[TBL] [Abstract][Full Text] [Related]
9. Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2.
Lee ES; Suzuki Y; Tomioka H; Nakagami H; Sato Y
Tohoku J Exp Med; 2023 Nov; 261(3):239-247. PubMed ID: 37704418
[TBL] [Abstract][Full Text] [Related]
10. Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.
Suenaga K; Kitahara S; Suzuki Y; Kobayashi M; Horie S; Sugawara J; Yaegashi N; Sato Y
PLoS One; 2014; 9(9):e104728. PubMed ID: 25184477
[TBL] [Abstract][Full Text] [Related]
11. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.
Mayevska O; Shuvayeva H; Igumentseva N; Havrylov S; Basaraba O; Bobak Y; Barska M; Volod'ko N; Baranska J; Buchman V; Drobot L
Exp Oncol; 2006 Dec; 28(4):275-81. PubMed ID: 17285110
[TBL] [Abstract][Full Text] [Related]
12. Vasohibin 2 promotes epithelial-mesenchymal transition in human breast cancer via activation of transforming growth factor β 1 and hypoxia dependent repression of GATA-binding factor 3.
Tu M; Li Z; Liu X; Lv N; Xi C; Lu Z; Wei J; Song G; Chen J; Guo F; Jiang K; Wang S; Gao W; Miao Y
Cancer Lett; 2017 Mar; 388():187-197. PubMed ID: 27867016
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and characterization of antibodies against clusterin].
Zhang YC; Liu Y; Yang JJ; Liu XL; Chi J; Gao JE; Tang XB; Zhu DL; Sun QH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jan; 24(1):45-8. PubMed ID: 18177618
[TBL] [Abstract][Full Text] [Related]
14. In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer.
Koyanagi T; Suzuki Y; Saga Y; Machida S; Takei Y; Fujiwara H; Suzuki M; Sato Y
Cancer Sci; 2013 Dec; 104(12):1705-10. PubMed ID: 24118388
[TBL] [Abstract][Full Text] [Related]
15. Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.
Kitahara S; Suzuki Y; Morishima M; Yoshii A; Kikuta S; Shimizu K; Morikawa S; Sato Y; Ezaki T
Mol Cancer; 2014 May; 13():99. PubMed ID: 24885408
[TBL] [Abstract][Full Text] [Related]
16. MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Xue X; Zhang Y; Zhi Q; Tu M; Xu Y; Sun J; Wei J; Lu Z; Miao Y; Gao W
Cell Commun Signal; 2014 Oct; 12():62. PubMed ID: 25269476
[TBL] [Abstract][Full Text] [Related]
17. [Preparation and characterization of anti-Amelotin polyclonal antibody].
Sun Y; Zhang JJ; Han TT; Li DL; Cao XM; Li WX; Gao YG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):328-31. PubMed ID: 19351503
[TBL] [Abstract][Full Text] [Related]
18. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
[TBL] [Abstract][Full Text] [Related]
19. Knockout of vasohibin-2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer.
Koyanagi T; Saga Y; Takahashi Y; Tamura K; Yoshiba T; Takahashi S; Taneichi A; Takei Y; Urabe M; Mizukami H; Fujiwara H
Cancer Med; 2021 Apr; 10(8):2732-2739. PubMed ID: 33710778
[TBL] [Abstract][Full Text] [Related]
20. The vasohibin family: Novel regulators of angiogenesis.
Sato Y
Vascul Pharmacol; 2012; 56(5-6):262-6. PubMed ID: 22286022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
